Pharma Journalist -

NightstaRx Ltd, a biopharmaceutical company specializing in developing gene therapies for inherited retinal dystrophies, announced the appointment of Scott M. Whitcup, M.D. to its board…
Read More...

Be The Match BioTherapies, an organization offering solutions for delivering autologous and allogeneic cellular therapies, today announced that it has entered into a strategic…
Read More...

Verastem focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced the appointment of Eric K. Rowinsky, MD to its Board…
Read More...

Aries Pharmaceuticals, Inc. (Aries) today announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable composition for…
Read More...

bluebird bio, Inc. announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with GlaxoSmithKline Intellectual Property…
Read More...

Pillsy, the first smart pill bottle and mobile app that helps users take control of their health and the health of others, has launched and is now available for purchase online. The…
Read More...

bluebird bio announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with Novartis Pharma AG. “bluebird bio is a pioneer in…
Read More...

BioAxone BioSciences, Inc., a clinical-stage biotechnology company focused on developing innovative drugs to restore neurological function, announced that it has entered a contract with…
Read More...

Nanotherapeutics Bohumil s.r.o. (a wholly owned subsidiary of Nanotherapeutics, Inc.) and Cyrus Poonawalla Group announced today the final transfer of Nanotherapeutics Bohumil s.r.o.’s…
Read More...

Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that it has initiated…
Read More...